SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-23-000210
Filing Date
2023-09-08
Accepted
2023-09-08 16:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4828
  Complete submission text file 0001973141-23-000210.txt   6285
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38295 | Film No.: 231245248
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134
Business Address
DiBiase Mary (Reporting) CIK: 0001880179 (see all company filings)

Type: 144